CV
curative ventures
Venture CapitalQuietCurative Ventures is a capital and talent partner to category-defining biotech companies.
4
Investments
3
Exits
$74M
AUM
75.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for curative ventures.
Investment Thesis & Strategy
Curative Ventures invests in various stages of biotech companies, providing both capital and talent to build category-defining companies.
Investment Activity
Deals per year over the last 5 years
1
20191
20205
20212
20221
2023Portfolio Companies
Selected investments from their portfolio of 4 companies
R
Rondo Therapeutics
Biotech · Series A, 2023
A
Acelyrin
Biotech · Series B, 2022
R
Rgenta Therapeutics
Biotech · Series A, 2022
C
Carmot Therapeutics
Biotech · Series B, 2021
V
Vera Therapeutics
Biotech · Series B, 2021
E
Enliven Therapeutics
Biotech · Series A, 2021
A
Apogee Therapeutics
Biotech · Series A, 2021
T
Triumvira Immunologics
Biotech · Series A, 2021
V
Ventyx Biosciences
Biotech · Series A, 2020
C
Cabaletta Bio
Biotech · Series A, 2019
Frequently Asked Questions
curative ventures focuses on Series A, Series B, Series C+ stage investments.
Related Investors
Sevin Rosen Funds
Dallas, United States · 212 deals
Green Park & Golf Ventures
Dallas, United States · 77 deals
CenterPoint Venture Partners
Dallas, United States · 54 deals
RevTech Ventures
Dallas, United States · 46 deals
Tech Wildcatters
Dallas, United States · 42 deals
Goldcrest Investments
Dallas, United States · 24 deals